MarineBiotech

Sea4Us is a company dedicated to transforming marine resources into innovative therapeutic solutions, focusing on bioactive compounds for unmet clinical needs such as chronic pain and neuropathies. It has developed methodologies for extracting natural compounds, tested in pre-clinical and clinical trials, resulting in patented drugs and chemically optimized versions of the original molecules (“Pharma” segment, NACE 72110). In addition to the pharmaceutical relevance of its patents, the company has identified opportunities in the nutraceutical and cosmeceutical markets, offering scientifically validated extracts and bioactive ingredients.

With MARINEbiotech, Sea4Us strengthens its strategic “Health” pillar by developing bioactive ingredients for the nutraceutical and cosmeceutical supplement markets, which have shorter time-to-market compared to new pharmaceutical products. The company’s strong R&D and pharmaceutical development expertise provides the new “Health” product line with a level of scientific validation that is rare in the nutraceutical and cosmeceutical segment, supporting market acceptance and a premium positioning based on proven quality and efficacy.

The project aims to create a production unit for the manufacturing and commercialization of bioactive ingredients derived from marine biomass, targeting the B2B market in the nutraceutical and cosmeceutical sector. This unit will enable the scaling of high-purity bioactive compound production, ensuring quality and sustainability, and reinforcing Sea4Us’s position as a reference in the blue economy.